What's happened
A clinical trial at University College London Hospitals aims to treat glioblastoma by injecting low levels of radioactivity directly into tumors. The first patient, Paul Read, has seen significant tumor reduction, raising hopes for improved outcomes in this aggressive cancer type.
Why it matters
What the papers say
According to BBC News, Paul Read, the first patient in the trial, experienced a remarkable reduction in his aggressive tumor, which was confirmed by his end-of-treatment scan. Dr. Paul Mulholland, the trial's chief investigator, emphasized the treatment's targeted nature, stating, "Because it's targeted directly to the tumour cells, it's very powerful at killing them."
The Independent reported that the trial aims to address the challenges of assessing glioblastoma's response to immunotherapy without invasive biopsies, which often carry risks. The new imaging technique developed could help identify patients who would benefit from such treatments, further enhancing the trial's significance.
In contrast, The Guardian highlighted the broader implications of ongoing research into glioblastoma, noting that the disease remains one of the most challenging cancers to treat. This trial represents a critical step forward in the quest for effective therapies, as noted by experts who stress the need for innovative approaches in cancer treatment.
How we got here
Glioblastoma is a highly aggressive brain cancer with a poor prognosis, often leading to death within 18 months. Traditional treatments have limited effectiveness, prompting the exploration of innovative therapies like the one being tested at UCLH.
More on these topics
-
Cancer Research UK is a cancer research and awareness charity in the United Kingdom and Isle of Man, formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund.
-
The National Institute for Health and Care Excellence is an executive non-departmental public body of the Department of Health in England, which publishes guidelines in four areas:
-
Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. Light colored stool or dark urine